Aurash Vatan

Aurash Vatan is a Machine Learning Intern at Nobias Therapeutics since May 2022. Concurrently, Vatan serves as a Columnist and Editorials Editor for The Harvard Crimson and is an Associate at the Harvard College Consulting Group, where involvement includes providing recommendations and measurements for a digital transformation project for a NASDAQ 100 semiconductor company through interviews, data analysis, and research. Vatan previously interned at the Middlesex District Attorney’s Office in the summer of 2018. Vatan is pursuing a Bachelor of Arts in Applied Mathematics at Harvard University, expected to graduate in 2023.